Deoxyribonuclease is prognostic in patients undergoing transcatheter aortic valve replacement.
Mangold A, Ondracek AS, Hofbauer TM, Artner T, Nechvile J, Panagiotides NG, Mirna M, Hammerer M, Fejzic D, Hoppe U, Wernly B, Lauten A, Alushi B, Franz M, Schulze PC, Wohlschläger-Krenn E, Lang IM, Lichtenauer M.
Mangold A, et al. Among authors: hofbauer tm.
Eur J Clin Invest. 2021 Nov;51(11):e13595. doi: 10.1111/eci.13595. Epub 2021 Jun 8.
Eur J Clin Invest. 2021.
PMID: 34101826